NERA Associate Director Dr. Jackie Chorn assisted L’Oréal USA in its successful BBB National Programs’ National Advertising Division (NAD) proceeding in which Johnson & Johnson Consumer Inc. (JJCI) challenged an advertising claim made about the CeraVe skincare brand by L’Oréal. In a reversal of its 2021 recommendation, the NAD concluded, with the support of Dr. Chorn’s survey evidence, that L’Oréal is justified in advertising CeraVe as the “#1 dermatologist-recommended skincare brand.”

Dr. Chorn used a novel survey methodology that the NAD noted “reliably captured dermatologists’ actual recommendation practices and…indicated that CeraVe is the clear leader in average weekly dermatologist recommendations.”

Click here to read more about the NAD's decision.